Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
On August 4, the Department of Health and Human Services released a Notice of Proposed Rulemaking on Nondiscrimination in Health Programs and Activities. In response, AMCP submitted comments on September 29 which applaud the Department's goal to reinstate regulatory protections from discrimination in covered health programs and activities.
September 2022 Legislative & Regulatory Briefing; AMCP Submits Comments to Improve the Medicare Advantage Program; New Member Benefit! Regulatory NewsBREAKS; AMCP Joins Request for PREP Act Declaration for Pharmacist Prescribing of Monkeypox Treatments; Request for Information: Make Your Voice Heard; ICYMI: August 2022 Legislative and Regulatory Briefing Webinar.
In this August 2022 webinar, join AMCP Policy & Government Relations staff for an overview of federal legislation, federal regulation, state legislation, and the federal election outlook.
On this episode of the AMCP Podcast Powered by PopHealth Week, co-hosts Fred Goldstein and Gregg Masters sit down with Steven G. Avey Award winner Dr. Mark McClellan and Executive Director of the AMCP Foundation, Paula J. Eichenbrenner.
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.